iBio (IBIO) Accumulated Expenses (2011 - 2026)
iBio's Accumulated Expenses was $5.63 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 318.3% from $1.35 million a year earlier and up 214.8% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Accumulated Expenses (2011 - 2026) Analysis & Trends
From fiscal Q4 2011 onward, iBio has reported Accumulated Expenses for 61 quarters.
- Accumulated Expenses shows a five-year compound annual growth rate of 13.4% (FY2021 to FY2026).
- In earlier fiscal years, Accumulated Expenses was $1.35 million in FY2025 (-33.7%), $2.03 million in FY2024 (-55.5%), $4.56 million in FY2023 (+21.2%) and $3.76 million in FY2022 (+25.4%).
- The fiscal Q4 2026 figure marks the highest quarterly Accumulated Expenses in data going back to fiscal Q4 2011.
- Compared with a year earlier, Accumulated Expenses was higher in two of the last eight quarters, with growth averaging 12.3%.
- The best year-over-year quarter for Accumulated Expenses over five years was fiscal Q4 2026 (growth of 318.3%); the worst was fiscal Q1 2025 (a decline of 68.2%).
- Per Business Quant data, IBIO's Accumulated Expenses in the three fiscal quarters before Q4 2026 was $1.79 million (Q3 2026), $1.58 million (Q2 2026) and $850,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | iBio | 122.79 Mn | 122.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.63 Mn |
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 850,000.00 |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 4.00 Mn |
| Dec 31, 2023 | 3.76 Mn |
| Sep 30, 2023 | 3.39 Mn |
| Jun 30, 2023 | 4.56 Mn |
| Mar 31, 2023 | 3.82 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 2.60 Mn |
| Jun 30, 2022 | 3.76 Mn |
| Mar 31, 2022 | 2.94 Mn |
| Dec 31, 2021 | 2.84 Mn |
| Sep 30, 2021 | 2.69 Mn |
API Access
iBio Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();